Jounce Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2016 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Jounce Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2016 to Q4 2022.
  • Jounce Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending December 31, 2022 was 51.7M shares, a 0.84% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 51.7M +429K +0.84% Dec 31, 2022 10-K/A 2023-04-28
Q3 2022 51.7M +454K +0.89% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 51.7M +460K +0.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 51.7M +474K +0.93% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 51.3M +9.54M +22.9% Dec 31, 2021 10-K/A 2023-04-28
Q3 2021 51.2M +17M +49.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 51.2M +17.2M +50.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 51.2M +17.2M +50.4% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 41.7M +7.99M +23.7% Dec 31, 2020 10-K 2022-03-02
Q3 2020 34.3M +1.06M +3.19% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 34.1M +1.08M +3.29% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 34M +1.08M +3.27% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 33.7M +790K +2.4% Dec 31, 2019 10-K 2021-02-25
Q3 2019 33.2M +526K +1.61% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 33M +375K +1.15% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 33M +509K +1.57% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 32.9M +683K +2.12% Dec 31, 2018 10-K 2020-02-27
Q3 2018 32.7M +471K +1.46% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 32.6M +425K +1.32% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 32.5M +292K +0.91% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 32.3M +29.7M +1181% Dec 31, 2017 10-K 2019-03-06
Q3 2017 32.2M Sep 30, 2017 10-Q 2017-11-13
Q2 2017 32.2M Jun 30, 2017 10-Q 2017-08-09
Q1 2017 32.2M Mar 31, 2017 10-Q 2017-05-09
Q4 2016 2.52M Dec 31, 2016 10-K 2018-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.